Dirk Lamprecht

8PUBLICATIONS
49CO-AUTHORS
Molecular targetsBiomolecular modelling and designGene and molecular therapyMicrobial geneticsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 22, 2025
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.

Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas

|Jun 18, 2025
Targeting de novo purine biosynthesis for tuberculosis treatment.

Dirk A Lamprecht, Richard J Wall, Annelies Leemans

|Aug 27, 2021
Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility.

Tafara T R Kunota, Md Aejazur Rahman, Barry E Truebody

|Dec 01, 2020
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis.

Jared S Mackenzie, Dirk A Lamprecht, Rukaya Asmal

|Jan 30, 2020
Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis.

Vikram Saini, Krishna C Chinta, Vineel P Reddy

Pageof 2